AGM/EGMApr 30, 2026, 05:03 PM
TELA 2026 Annual Meeting; Board Refreshment, Equity Plan Increase
AI Summary
TELA Bio, Inc. announced its 2026 Annual Meeting of Stockholders to be held virtually on June 9, 2026. Key proposals include the election of three Class I directors, ratification of KPMG LLP as auditor, and an advisory vote on executive compensation. The company also seeks approval to increase authorized shares under its 2019 Equity Incentive Plan by 3,500,000. Significant board refreshment is underway, with several directors departing and new members nominated, including Joseph Capper as the new Chairman. The filing also highlighted strong Q4 2025 revenue of $20.9 million and full-year revenue of $80.3 million, alongside a new credit facility and a recent stock offering.
Key Highlights
- 2026 Annual Meeting of Stockholders to be held virtually on June 9, 2026.
- Proposes election of Joseph Capper, William Plovanic, Betty Jo Rocchio as Class I directors.
- Doug Evans not standing for re-election; Joseph Capper nominated as Chairman of the Board.
- Board refreshment: Kurt Azarbarzin, Vince Burgess, Federica O’Brien resigned effective April 29, 2026.
- Guido Neels, Guy Nohra, Paul Thomas to join Board as directors post-Annual Meeting.
- Proposes to increase authorized shares under 2019 Equity Incentive Plan by 3,500,000 shares.
- Q4 2025 revenue $20.9 million (+18% YoY); FY 2025 revenue $80.3 million (+16% YoY).
- Closed $70.0 million credit facility; $11.6 million net proceeds from stock offering.